Shire gets approval for its Gaucher drug.
AstraZeneca buying out Merck‘s interest in certain jointly-marketed products.
Executive Leadership – Yes, even the top echelon folks need coaching and training to continue their development. We’ve got the providers you need in the Impactiviti network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
Some new primary-care doctors are going for a cash-only practice (from KevinMD). Can hardly blame them – soon all the government/regulatory/insurance nonsense will bring back the barter system!
JUST FOR FUN
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board